Summary
BITTER PILL: GlaxoSmithKline is facing potential criminal prosecution in the UK for allegedly not informing health regulators about the risks of higher suicide rates among users of its flagship anti-depressant, Seroxat, writes Karl West.
The Medicines and Healthcare Products Regulatory Agency has launched an investigation into Glaxo over concerns that the drugs giant had withheld important information from clinical trials, according to reports.See the full content of this document
Extract
Bad Memo Day for Glaxo
The suppressed data showed that Seroxat could cause an increased risk of suicide ...
See the full content of this document
Sponsored links
